NIH Awards $7M Contract to CDI for iPS Cell Lines, Differentiated Tissue Cells | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that the National Institutes of Health Center for Regenerative Medicine has awarded it a contract for up to $7 million over three years to provide human induced pluripotent stem cell lines and terminally differentiated tissue cells from normal or specified patient populations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.